HONG KONG – The Central Drugs Standard Control Organization (CDSCO) of India is setting up a national database, known as Sugam, of pharmaceutical manufacturers and their medicines to help address drug shortages and quality issues.
HONG KONG – The Central Drugs Standard Control Organization (CDSCO) of India is setting up a national database, known as Sugam, of pharmaceutical manufacturers and their medicines to help address drug shortages and quality issues.
HONG KONG – China's Zai Lab Ltd. has returned the exclusive sales license of lung cancer drug Olita Tab (olmutinib) to its developer, South Korea's Hanmi Pharmaceutical Co. Ltd., a move Zai attributed to reprioritization, though Olita Tab has run into problems in clinical studies.
HONG KONG – The Trump administration has proposed placing a 25 percent tariff on more than 1,300 imported goods from China, such as biotech materials and medical devices, a move some say could eventually hurt U.S. drugmakers.
HONG KONG – China's Zai Lab Ltd. has returned the exclusive sales license of lung cancer drug Olita Tab (olmutinib) to its developer, South Korea's Hanmi Pharmaceutical Co. Ltd., a move Zai attributed to reprioritization, though Olita Tab has run into problems in clinical studies.
HONG KONG – The Trump administration has proposed placing a 25 percent tariff on more than 1,300 imported goods from China, such as biotech materials and medical devices, a move some say could eventually hurt U.S. drugmakers.
HONG KONG – Japan's Carna Biosciences Inc. and Sumitomo Dainippon Pharma Co. Ltd. signed an agreement potentially worth about $100 million to work together on the research, development and commercialization of novel kinase inhibitors, focusing on psychiatric and neurological disorders.
